Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $15,000 | 1 | 91.9% |
| Food and Beverage | $1,261 | 41 | 7.7% |
| Travel and Lodging | $60.03 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $15,000 | 1 | $0 (2020) |
| ABBVIE INC. | $699.13 | 28 | $0 (2024) |
| Abbott Laboratories | $251.21 | 5 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $125.00 | 1 | $0 (2022) |
| PFIZER INC. | $63.36 | 3 | $0 (2024) |
| Medtronic, Inc. | $58.66 | 1 | $0 (2024) |
| ARGENX US, INC. | $52.37 | 2 | $0 (2023) |
| Boston Scientific Corporation | $50.45 | 2 | $0 (2024) |
| Eisai Inc. | $21.12 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $873.83 | 34 | ABBVIE INC. ($686.13) |
| 2023 | $295.10 | 7 | Abbott Laboratories ($213.32) |
| 2022 | $152.37 | 2 | Merz Pharmaceuticals, LLC ($125.00) |
| 2020 | $15,000 | 1 | Medtronic USA, Inc. ($15,000) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Neuromodulation | ||||||
| 12/31/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $33.99 | General |
| Category: General - DBS_NMD | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Neurology | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 302 | 5,138 | $406,535 | $77,139 |
| 2022 | 5 | 196 | 254 | $186,090 | $37,214 |
| 2021 | 2 | 22 | 22 | $17,127 | $2,997 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 107 | 185 | $137,825 | $28,664 | 20.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 14 | 4,750 | $92,202 | $23,562 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 54 | 54 | $57,510 | $10,035 | 17.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 31 | $21,700 | $3,698 | 17.0% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 11 | 20 | $41,960 | $2,863 | 6.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 20 | $14,300 | $2,081 | 14.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $16,992 | $1,942 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $8,800 | $1,783 | 20.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 20 | $10,380 | $1,404 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $4,500 | $956.28 | 21.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 18 | $366.00 | $151.20 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 79 | 134 | $99,830 | $21,889 | 21.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 58 | 58 | $61,770 | $11,107 | 18.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 24 | 24 | $12,600 | $2,315 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 21 | $11,550 | $1,852 | 16.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 17 | $340.00 | $50.43 | 14.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $10,967 | $1,792 | 16.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $6,160 | $1,205 | 19.6% |
About Dr. Rebecca Lalchan-Narine, D.O
Dr. Rebecca Lalchan-Narine, D.O is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1578911533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Lalchan-Narine, D.O has received a total of $16,321 in payments from pharmaceutical and medical device companies, with $873.83 received in 2024. These payments were reported across 44 transactions from 9 companies. The most common payment nature is "Grant" ($15,000).
As a Medicare-enrolled provider, Lalchan-Narine has provided services to 520 Medicare beneficiaries, totaling 5,414 services with total Medicare billing of $117,350. Data is available for 3 years (2021–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Brooklyn, NY
- Active Since 06/01/2016
- Last Updated 09/08/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1578911533
Products in Payments
- ACTIVA (Device) $15,000
- BOTOX (Biological) $537.98
- INFINITY (Device) $251.21
- Xeomin (Biological) $125.00
- QULIPTA (Drug) $86.92
- PERCEPT PC BRAINSENSE (Device) $58.66
- VYVGART (Drug) $52.37
- PAXLOVID (Drug) $43.78
- UBRELVY (Drug) $37.91
- Leqembi (Drug) $21.12
- NURTEC ODT (Drug) $19.58
- DUOPA (Drug) $18.79
- VYALEV (Drug) $17.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680